Drug intelligence / Profile preview

ibuprofen + ondansetron

Development stage
Unknown
Lead developer
Hackensack Meridian Health
Modality
Small Molecules
Administration
Oral
01

Overview

Ibuprofen + ondansetron is a combination drug regimen being evaluated by Hackensack Meridian Health for the management of side effects associated with medical abortion. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis to alleviate pain and inflammation. Ondansetron is a selective 5-HT3 receptor antagonist that prevents nausea and vomiting by blocking serotonin receptors in the gastrointestinal tract and the chemoreceptor trigger zone. The combination is specifically studied as a prophylactic regimen to improve patient satisfaction and reduce the incidence of pain and nausea following misoprostol administration in patients undergoing medical abortion at less than 70 days of gestation.

Other names
ibuprofen and ondansetronProphylactic Analgesic and Antiemetic Regimen
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on ibuprofen + ondansetron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibuprofen + ondansetron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call